Literature DB >> 9482513

Arterial calcifications in beta-thalassemia.

A Aessopos1, M Samarkos, E Voskaridou, D Papaioannou, M Tsironi, E Kavouklis, G Vaiopoulos, G Stamatelos, D Loukopoulos.   

Abstract

The purpose of this study was to define the incidence of arterial calcifications in patients with beta-thalassemia. Beta-thalassemia patients have been shown to present a high prevalence of angioid streaks and skin lesions characteristic of pseudoxanthoma elasticum (PXE). Given the fact that vascular involvement in the form of arterial calcifications is also a common manifestation of PXE, the authors investigated radiographically the presence of arterial calcifications in beta-thalassemia patients. They studied 40 patients with beta-thalassemia over 30 years of age. Forty healthy, age- and sex-matched subjects were chosen as a control group. Radiographs of the tibias were performed in order to disclose arterial calcifications. The occurrence of PXE skin lesions and of angioid streaks (AS) was also investigated. Arterial calcifications were detected in the posterior tibial artery in 22 (55%) beta-thalassemia patients and in six (15%) controls (P < 0.01 for the comparison). PXE skin lesions and AS were found in eight (20%) and 21 (52%) patients respectively. A total of 34 patients (85%) had at least one of the three lesions, namely, arterial calcifications, angioid streaks, and/or PXE-like skin lesions. Stepwise logistic regression analysis did not reveal prognostic value in independent variables such as transfusions, chelation therapy, pseudoxanthoma elasticum skin lesions and/or angioid streaks, diabetes, hemoglobin, serum ferritin, and uric acid. It was concluded that arterial calcifications are common in older beta-thalassemia patients. This finding could be a manifestation of an acquired PXE syndrome associated with beta-thalassemia, and consequently, vascular events complicating PXE should be expected in these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9482513     DOI: 10.1177/000331979804900206

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  11 in total

1.  A mouse model of β-thalassemia shows a liver-specific down-regulation of Abcc6 expression.

Authors:  Ludovic Martin; Vanessa Douet; Christopher M VanWart; Matthew B Heller; Olivier Le Saux
Journal:  Am J Pathol       Date:  2011-02       Impact factor: 4.307

2.  Loss of vision associated with angioid streaks in beta-thalassemia intermedia.

Authors:  Athanasios Aessopos; Charalampos S Floudas; Maria Kati; Maria Tsironi; Xanthoula Giakoumi; Charalampos Livir-Rallatos; Dimitrios Farmakis
Journal:  Int J Hematol       Date:  2007-12-11       Impact factor: 2.490

3.  Cardiac function and iron chelation in thalassemia major and intermedia: a review of the underlying pathophysiology and approach to chelation management.

Authors:  Athanasios Aessopos; Vasilios Berdoukas
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-07-18       Impact factor: 2.576

Review 4.  Non-Transfusion-Dependent Thalassemia: An Update on Complications and Management.

Authors:  Joseph Sleiman; Ali Tarhini; Rayan Bou-Fakhredin; Antoine N Saliba; Maria Domenica Cappellini; Ali T Taher
Journal:  Int J Mol Sci       Date:  2018-01-08       Impact factor: 5.923

Review 5.  Medial vascular calcification revisited: review and perspectives.

Authors:  Peter Lanzer; Manfred Boehm; Victor Sorribas; Marc Thiriet; Jan Janzen; Thomas Zeller; Cynthia St Hilaire; Catherine Shanahan
Journal:  Eur Heart J       Date:  2014-04-16       Impact factor: 29.983

6.  Fibroblast involvement in soft connective tissue calcification.

Authors:  Ivonne Ronchetti; Federica Boraldi; Giulia Annovi; Paolo Cianciulli; Daniela Quaglino
Journal:  Front Genet       Date:  2013-03-05       Impact factor: 4.599

7.  The vascular phenotype in Pseudoxanthoma elasticum and related disorders: contribution of a genetic disease to the understanding of vascular calcification.

Authors:  Georges Lefthériotis; Loukman Omarjee; Olivier Le Saux; Daniel Henrion; Pierre Abraham; Fabrice Prunier; Serge Willoteaux; Ludovic Martin
Journal:  Front Genet       Date:  2013-02-12       Impact factor: 4.599

8.  Effect of heterozygous beta-thalassaemia trait on coronary atherosclerosis via coronary artery disease risk factors: a preliminary study.

Authors:  M Hashemi; E Shirzadi; Z Talaei; L Moghadas; I Shaygannia; M Yavari; N Amiri; H Taheri; H Montazeri; H Shamsolkottabi
Journal:  Cardiovasc J Afr       Date:  2007 May-Jun       Impact factor: 1.167

9.  Use of strain, strain rate, tissue velocity imaging, and endothelial function for early detection of cardiovascular involvement in patients with beta-thalassemia.

Authors:  Abhinav Gupta; Aditya Kapoor; Shubha Phadke; Archana Sinha; Shridhar Kashyap; Roopali Khanna; Sudeep Kumar; Naveen Garg; Satyendra Tewari; Pravin Goel
Journal:  Ann Pediatr Cardiol       Date:  2017 May-Aug

10.  Spectral domain optical coherence tomography findings in Turkish sickle-cell disease and beta thalassemia major patients.

Authors:  Mahmut Oğuz Ulusoy; Hakan Türk; Sertaç Argun Kıvanç
Journal:  J Curr Ophthalmol       Date:  2019-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.